Singapore, Sept. 20, 2025 (GLOBE NEWSWIRE) -- 15 September 2025 Singapore, Singapore — Coinstore has announced the official IEO of…
Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR®…
Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with…
TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology…
New York City, NY, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Introduction – What is Bravo Flowdex Bravo Flowdex is a…
New York City, NY, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Introduction to Net Rowdex Net Rowdex emerges in 2025 as…
New York City, NY, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Introduction to Immediate Edge Immediate Edge is a cutting-edge AI-powered…
September 20, 2025 11:00 ET | Source: C4 Therapeutics, Inc. Cemsidomide in Combination With Dexamethasone Achieved a 50% Overall Response…
NORWALK, Conn., Sept. 20, 2025 (GLOBE NEWSWIRE) -- Today, the Multiple Myeloma Research Foundation® (MMRF) announced that data generated from…
September 19, 2025 16:18 ET | Source: MBX Biosciences, Inc. CARMEL, Ind., Sept. 19, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences,…